Mark M. Applefeld

1.1k total citations
25 papers, 748 citations indexed

About

Mark M. Applefeld is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark M. Applefeld has authored 25 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark M. Applefeld's work include Heart Failure Treatment and Management (8 papers), Pericarditis and Cardiac Tamponade (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Mark M. Applefeld is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Pericarditis and Cardiac Tamponade (5 papers) and Chemotherapy-induced cardiotoxicity and mitigation (4 papers). Mark M. Applefeld collaborates with scholars based in United States. Mark M. Applefeld's co-authors include Peter H. Wiernik, David S. Roffman, William P. Reed, William R. Grove, Kathryn A. Newman, Clinton N. Corder, Richard B. Hornick, Kirkwood F. Adams, Benoı̂t Mâsse and Mordecai P. Blaustein and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Cancer.

In The Last Decade

Mark M. Applefeld

24 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark M. Applefeld United States 17 524 173 145 127 77 25 748
G Grötte United Kingdom 13 348 0.7× 180 1.0× 94 0.6× 112 0.9× 62 0.8× 29 646
Leidulf Segadal Norway 16 472 0.9× 265 1.5× 173 1.2× 140 1.1× 67 0.9× 42 783
İlhan Paşaoğlu Türkiye 13 376 0.7× 408 2.4× 288 2.0× 128 1.0× 38 0.5× 63 977
B. Hadley Wilson United States 15 419 0.8× 192 1.1× 98 0.7× 142 1.1× 72 0.9× 27 715
Richard D. Sautter United States 19 346 0.7× 262 1.5× 301 2.1× 58 0.5× 61 0.8× 50 975
Claudio Picariello Italy 19 659 1.3× 194 1.1× 79 0.5× 102 0.8× 120 1.6× 68 973
B.L. Chia Singapore 16 535 1.0× 247 1.4× 173 1.2× 143 1.1× 25 0.3× 88 876
P Alstrup Denmark 12 333 0.6× 259 1.5× 123 0.8× 143 1.1× 40 0.5× 40 584
H Warembourg France 21 930 1.8× 536 3.1× 456 3.1× 171 1.3× 65 0.8× 153 1.5k
Gaetano Ruocco Italy 20 668 1.3× 191 1.1× 293 2.0× 97 0.8× 93 1.2× 75 1.0k

Countries citing papers authored by Mark M. Applefeld

Since Specialization
Citations

This map shows the geographic impact of Mark M. Applefeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Applefeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Applefeld more than expected).

Fields of papers citing papers by Mark M. Applefeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Applefeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Applefeld. The network helps show where Mark M. Applefeld may publish in the future.

Co-authorship network of co-authors of Mark M. Applefeld

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Applefeld. A scholar is included among the top collaborators of Mark M. Applefeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Applefeld. Mark M. Applefeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patterson, J. Herbert, Kirkwood F. Adams, Mark M. Applefeld, Clinton N. Corder, & Benoı̂t Mâsse. (1995). Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.. PubMed. 14(5). 514–21. 45 indexed citations
2.
Patterson, J. Herbert, et al.. (1994). Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(5). 514–521. 42 indexed citations
3.
Applefeld, Mark M.. (1990). The Jugular Venous Pressure and Pulse Contour. Europe PMC (PubMed Central). 18 indexed citations
4.
Applefeld, Mark M., et al.. (1990). A NEW DIRECTION FOR DOBUTAMINE. Nursing. 20(10). 42–42. 1 indexed citations
5.
Tommaso, Carl L., et al.. (1988). Isolated left main coronary artery stenosis and mediastinal radiotherapy as an etiologic factor. The American Journal of Cardiology. 61(13). 1119–1120. 10 indexed citations
6.
Applefeld, Mark M., et al.. (1987). Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients. American Heart Journal. 114(3). 589–595. 67 indexed citations
7.
Hassan, Erkan, David S. Roffman, & Mark M. Applefeld. (1987). The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure. American Heart Journal. 113(3). 743–749. 16 indexed citations
8.
Applefeld, Mark M.. (1986). Chronic congestive heart failure: Where have we been? Where are we heading?. The American Journal of Medicine. 80(2). 73–77. 16 indexed citations
9.
Whitley, Nancy O., et al.. (1985). The role of echocardiography and computed tomography in the evaluation of constrictive pericarditis. American Heart Journal. 109(2). 350–355. 35 indexed citations
10.
Roffman, David S., et al.. (1985). Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.. PubMed. 4(2). 195–9. 28 indexed citations
11.
Applefeld, Mark M., Kathryn A. Newman, William R. Grove, et al.. (1983). Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. The American Journal of Cardiology. 51(3). 455–458. 59 indexed citations
12.
Applefeld, Mark M. & Peter H. Wiernik. (1983). Cardiac disease after radiation therapy for Hodgkin's disease: Analysis of 48 patients. The American Journal of Cardiology. 51(10). 1679–1681. 83 indexed citations
13.
Applefeld, Mark M., et al.. (1982). Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy.. PubMed. 66(4). 1003–13. 47 indexed citations
14.
Connor, Thomas B., et al.. (1982). Hypocalcemia Precipitating Congestive Heart Failure. New England Journal of Medicine. 307(14). 869–872. 77 indexed citations
15.
Applefeld, Mark M., et al.. (1981). Delayed pericardial disease after radiotherapy. The American Journal of Cardiology. 47(2). 210–213. 21 indexed citations
16.
Applefeld, Mark M., et al.. (1981). The Late Appearance of Chronic Pericardial Disease in Patients Treated by Radiotherapy for Hodgkin's Disease. Annals of Internal Medicine. 94(3). 338–341. 71 indexed citations
17.
Applefeld, Mark M., et al.. (1980). Congestive heart failure and endocardial fibroelastosis caused by chronic lymphocytic leukemia. Cancer. 46(6). 1479–1484. 11 indexed citations
18.
Applefeld, Mark M., et al.. (1980). Cardiac disease in patients who have malignancies. Current Problems in Cardiology. 4(11). 4–37. 17 indexed citations
19.
Mikulski, Stanislaw M., et al.. (1979). Aspergillus Vegetative Endocarditis and Complete Heart Block in a Patient with Acute Leukemia. CHEST Journal. 76(4). 473–476. 16 indexed citations
20.
Applefeld, Mark M., et al.. (1977). Traumatic Left Anterior Descending Coronary Artery to Right Ventricle Fistula. Southern Medical Journal. 70(5). 581–584. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Grötte Breakdown of academic impact, for papers by Leidulf Segadal Breakdown of academic impact, for papers by İlhan Paşaoğlu Breakdown of academic impact, for papers by B. Hadley Wilson Breakdown of academic impact, for papers by Richard D. Sautter Breakdown of academic impact, for papers by Claudio Picariello Breakdown of academic impact, for papers by B.L. Chia Breakdown of academic impact, for papers by P Alstrup Breakdown of academic impact, for papers by H Warembourg Breakdown of academic impact, for papers by Gaetano Ruocco
Rankless by CCL
2026